News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Conatus Pharmaceuticals Inc. Sets Terms for $55 Million IPO


7/10/2013 7:58:48 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Conatus Pharmaceuticals, a biotech focused on the development of novel medicines to treat liver disease, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $55 million by offering 5 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Conatus Pharmaceuticals would command a fully diluted market value of $160 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at Xconomy

comments powered by Disqus
Nasdaq
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES